XWELL, Inc. (XWEL)
NASDAQ: XWEL · Real-Time Price · USD
0.9500
-0.0500 (-5.00%)
At close: Jun 27, 2025, 4:00 PM
0.9700
+0.0200 (2.11%)
After-hours: Jun 27, 2025, 7:50 PM EDT
XWELL Revenue
XWELL had revenue of $7.02M in the quarter ending March 31, 2025, a decrease of -19.52%. This brings the company's revenue in the last twelve months to $32.19M, up 1.33% year-over-year. In the year 2024, XWELL had annual revenue of $33.90M with 12.58% growth.
Revenue (ttm)
$32.19M
Revenue Growth
+1.33%
P/S Ratio
0.14
Revenue / Employee
$103,186
Employees
312
Market Cap
5.00M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 33.90M | 3.79M | 12.58% |
Dec 31, 2023 | 30.11M | -25.83M | -46.18% |
Dec 31, 2022 | 55.94M | -17.79M | -24.13% |
Dec 31, 2021 | 73.73M | 65.34M | 779.30% |
Dec 31, 2020 | 8.39M | -38.92M | -82.28% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
XWEL News
- 1 day ago - Xpres Spa Named One of Yelp's Most Loved Airport Brands - GlobeNewsWire
- 11 days ago - XWELL Named Official Wellness Spa of the Orlando Magic - GlobeNewsWire
- 5 weeks ago - Xpres Spa Elevates the Travel Experience with New Wellness Benefits for Priority Pass Members - GlobeNewsWire
- 5 weeks ago - XWELL Reports First Quarter 2025 Results, Advancing Mission to Liberate Science-Proven Wellness - GlobeNewsWire
- 2 months ago - XWELL Reports Fiscal Year 2024 Results - GlobeNewsWire
- 3 months ago - XWELL Announces Plan for Strategic Investment in Medical Spas to Advance Wellness and Beauty Offerings - GlobeNewsWire
- 5 months ago - XWELL Announces Closing of $4 Million Private Placement Consisting of Convertible Preferred Stock and Warrants - GlobeNewsWire
- 6 months ago - XWELL Announces Senior Leadership Appointments and Changes - GlobeNewsWire